Telix Pharmaceuticals Limited Stock Analysis

Telix Pink Sheet Analysis Notes

About 28.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.2. Telix Pharmaceuticals had not issued any dividends in recent years. Telix Pharmaceuticals Limited, a radiopharmaceutical company, develops molecularly targeted radiation products for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company was founded in 2015 and is headquartered in North Melbourne, Australia. Telix Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Telix Pharmaceuticals Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Telix Pharmaceuticals Limited contact the company at 61 3 3093 3897 or learn more at https://telixpharma.com.

Telix Pharmaceuticals Investment Alerts

Telix Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.44 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Telix Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Telix Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 23rd of November, Telix Pharmaceuticals has the Semi Deviation of 3.74, coefficient of variation of 3018.41, and Risk Adjusted Performance of 0.0333. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Telix Pharmaceuticals, as well as the relationship between them. Please validate Telix Pharmaceuticals standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if Telix Pharmaceuticals is priced more or less accurately, providing market reflects its prevalent price of 14.1 per share. Given that Telix Pharmaceuticals has jensen alpha of 0.063, we advise you to double-check Telix Pharmaceuticals Limited's current market performance to make sure the company can sustain itself at a future point.

Telix Pharmaceuticals Price Movement Analysis

Telix Pharmaceuticals Predictive Daily Indicators

Telix Pharmaceuticals Forecast Models

Telix Pharmaceuticals' time-series forecasting models are one of many Telix Pharmaceuticals' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Telix Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Telix Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Telix shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Telix Pharmaceuticals. By using and applying Telix Pink Sheet analysis, traders can create a robust methodology for identifying Telix entry and exit points for their positions.

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.